Latest filing published 14 Jun 2016 for Aralez Pharmaceuticals Inc., €20k.
Insider track record
No signal scores available.
Neal Franklin Fowler: trading record in brief
All filings by Neal Franklin Fowler on record concern Aralez Pharmaceuticals Inc. We count 2 filings; the first trade dates from 5 February 2016 and the latest from 10 June 2016.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 14 June 2016 came the latest disclosure, an option exercise for €20k in Aralez Pharmaceuticals Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Neal Franklin Fowler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,139 shares@ CA$3.58100.0% of flowCommon SharesTSXSEDI:2851541
- Common SharesTSXSEDI:2787437
2 of 2 declarations
